Neoadjuvant Immunotherapy in Melanoma: Where We Are and Where We Aren't

被引：0
|
作者：
Patel, Sapna P. [1 ,2 ,3 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr Houston, Dept Melanoma Med Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr Houston, Uveal Melanoma Program, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr Houston, Melanoma Fellowship Program, Houston, TX 77030 USA
来源：
ONCOLOGY-NEW YORK | 2023年 / 37卷 / 10期
关键词：
ADJUVANT;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：36
相关论文
共 50 条
  • [11] Neoadjuvant Treatments for Pancreatic Ductal Adenocarcinoma: Where We Are and Where We Are Going
    Coppola, Alessandro
    Farolfi, Tommaso
    La Vaccara, Vincenzo
    Iannone, Immacolata
    Giovinazzo, Francesco
    Panettieri, Elena
    Tarallo, Mariarita
    Cammarata, Roberto
    Coppola, Roberto
    Caputo, Damiano
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (11)
  • [12] Melanoma in pregnancy - where we are?
    Izycki, Dariusz
    Kerrigan, Christopher Patrick
    Kazmierczak, Maciej
    [J]. PRZEGLAD MENOPAUZALNY, 2013, 12 (06): : 493 - 495
  • [13] Melanoma etiology: where are we?
    Tucker, MA
    Goldstein, AM
    [J]. ONCOGENE, 2003, 22 (20) : 3042 - 3052
  • [14] Immunotherapy for head and neck cancer: where are we now and where are we going?
    Bauml, Joshua M.
    Aggarwal, Charu
    Cohen, Roger B.
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [15] Melanoma etiology: where are we?
    Margaret A Tucker
    Alisa M Goldstein
    [J]. Oncogene, 2003, 22 : 3042 - 3052
  • [16] Immunotherapy for esophageal cancer: Where are we now and where can we go
    Shoji, Yoshiaki
    Koyanagi, Kazuo
    Kanamori, Kohei
    Tajima, Kohei
    Ogimi, Mika
    Ninomiya, Yamato
    Yamamoto, Miho
    Kazuno, Akihito
    Nabeshima, Kazuhito
    Nishi, Takayuki
    Mori, Masaki
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (19)
  • [17] Immunotherapy of Type 1 Diabetes: Where Are We and Where Should We Be Going?
    Luo, Xunrong
    Herold, Kevan C.
    Miller, Stephen D.
    [J]. IMMUNITY, 2010, 32 (04) : 488 - 499
  • [18] Where We Are, Where We Are Not
    Carlisle, Chuck
    [J]. CONFRONTATION, 2009, (105-06): : 270 - 270
  • [19] Where We Were, Where We Are, Where We Are Going
    Epstein, Burton S.
    [J]. ANESTHESIA AND ANALGESIA, 2011, 113 (03): : 480 - 483
  • [20] ASO Author Reflections: Neoadjuvant Treatment for Melanoma—Where Are We Now?
    Cimarron E. Sharon
    Giorgos C. Karakousis
    [J]. Annals of Surgical Oncology, 2022, 29 : 8501 - 8502
12345